Institutional Equity Research for Undercovered Public Companies
Alliance Equity Research publishes independent and company-sponsored research on undercovered, emerging, and high-potential public companies globally.
Search AER-covered companies and Insights, or explore listed companies across global markets.
Latest Research
Recent initiation reports, research updates and company commentary from Alliance Equity Research.
ASML Holding N.V.
ASML
A Near-Monopoly Lithography Franchise Powering Global Semiconductor Supply Chain with EUV Dominance and High-NA Optionality
Initiation coverage examining EUV leadership, High-NA optionality, DUV economics, installed-base services, competitive moat, semiconductor demand drivers, valuation summary, and key risks.
Dexcom, Inc.
DXCM
Dominant CGM Franchise Leveraging Technology, Coverage Expansion, and Consumer Tailwinds to Sustain Multi-Year Growth
Initiation coverage examining CGM market leadership, product strategy, reimbursement expansion, recurring sensor economics, international growth, valuation summary, and key risks.
Insights
Timely analysis of company developments, industry trends, capital markets activity, and emerging investment themes across global public markets.
Mining & Critical MineralsUS Lime’s Texas Kiln Nears Commissioning as Higher Costs Offset Revenue Growth
United States Lime & Minerals increased third-quarter revenue as prices and shipment volumes improved, but higher fuel and transportation costs and inefficiencies at its new Texas kiln reduced profit. The expansion is approaching final commissioning just as management reports construction delays and signs of slower Texas housing activity. Strong cash generation and a debt-free balance sheet provide flexibility, while the investment assessment depends on whether the new asset can improve production economics, cover its forthcoming depreciation charge and earn attractive returns as customer demand changes.
Biotechnology & HealthcareINOVIO’s Voceryq Approval Shifts Attention to Patient Uptake, Competition and Launch Funding
INOVIO’s first approved DNA medicine offers a new approach to reducing airway surgery. Commercial adoption will depend on its treatment profile, reimbursement and competition, while management’s disclosed cash runway overlaps the planned launch quarter and continuing clinical obligations extend beyond it.
EnergyCapital Clean Energy Carriers’ Larger Fleet Lifts Earnings as 2027 Vessel Payments Approach
CCEC’s third-quarter revenue and earnings increased as new ships entered service. Large payments in early 2027 bring the funding plan into focus. Existing charters and operating cash provide support, while borrowing terms and exposure to market-linked rates shape the cash ultimately retained for shareholders.
EnergyForum Energy Technologies Raises Guidance as Stronger Margins and Cash Flow Reduce Debt
Forum Energy Technologies' third-quarter results show improving profitability across its oilfield equipment businesses, with orders remaining above sales and net leverage falling below one times adjusted EBITDA. Its raised annual outlook depends on sustaining recent margins and converting working capital into cash through year-end.
Technology & SemiconductorsBel Fuse’s Data Business Drives Sales Growth and Higher Manufacturing Margins
Bel Fuse’s data-related products are lifting sales and factory margins, with growth extending beyond its identifiable AI customers. Fourth-quarter guidance supports continued demand, while a larger share count, Enercon’s minority-interest valuation and inventory investment shape how operating gains translate into shareholder earnings and cash.
Industrials & AerospaceAecon’s Record Backlog Strengthens Growth Visibility, With Contract Mix Shaping the Earnings Upside
Aecon’s C$14.6 billion backlog and stronger third-quarter margins support further growth in power and infrastructure construction. A shift toward variable-price and collaboratively developed contracts could improve earnings predictability, while unusually strong cash receipts help finance a C$320 million utility buyout.
Biotechnology & HealthcareLigand’s First Results With XOMA Show Royalty Growth Beyond the Acquisition
Ligand’s first results with XOMA show a larger royalty base and continued growth in the legacy portfolio. Lower acquired overhead offers an earnings benefit, while the deal increases capital committed and debt. Year-end guidance also depends on stronger Captisol orders and contract income alongside royalties.
Mining & Critical MineralsFireFly’s Cash Gives Green Bay Financing Flexibility Ahead of a 2027 Investment Decision
FireFly’s A$337.1 million cash balance strengthens its position as Green Bay approaches feasibility and construction financing. For shareholders, the benefit depends on the remaining capital requirement and funding terms. The larger mine plan offers more production, accompanied by additional investment and a longer development programme.
Explore Coverage
AER-covered companies combine public-company information with our proprietary research, updates, and commentary.
Find AER-Covered Companies
Explore AER-covered companies by sector, region, and market capitalization.
Research Built Around the Model
Alliance Equity Research develops written company analysis and detailed financial models together. The model is used to test operating assumptions, financial outcomes, scenarios, and valuation frameworks.
- Fundamental company analysis
- Integrated financial modeling
- Scenario-based valuation framework
- Ongoing coverage after initiation
Operating Drivers
RevenuePricingVolumeKPIsFinancial Forecast
Illustrative forecast structure, without financial values Metric FY1 FY2 FY3 FY4 Revenue Forecast output placeholder Forecast output placeholder Forecast output placeholder Forecast output placeholder EBITDA Forecast output placeholder Forecast output placeholder Forecast output placeholder Forecast output placeholder FCF Forecast output placeholder Forecast output placeholder Forecast output placeholder Forecast output placeholder Scenarios & Sensitivities
BaseUpsideDownsideValuation
DCF · Trading Multiples
Published Research
Is Your Company Undercovered?
Alliance Equity Research works with listed companies, recently listed companies, and businesses preparing to list, with a focus on undercovered, emerging, and high-potential opportunities. Our coverage includes initiation research, detailed financial modeling, and ongoing research updates.
- Initiation Research
- Financial Model
- Ongoing Updates
Investor Discovery
- AER Website
- FactSet
- LSEG Refinitiv
- AlphaSense
- Distribution Partners
Stay Current with AER
Choose the research and Insights updates you want to receive.